Opportunity Information: Apply for RFA DA 22 049
The National Institutes of Health (NIH) released this funding opportunity, RFA-DA-22-049, under the HEAL (Helping to End Addiction Long-term) Initiative to establish a single Modeling and Economic Resource Center that will serve the broader HEAL Data2Action (D2A) Program. The award mechanism is a U24 cooperative agreement (clinical trial optional), which typically means the funded center will work in close coordination with NIH and with other HEAL D2A awardees, providing shared expertise and deliverables rather than operating as a stand-alone research project. The overall aim is practical: give HEAL D2A Innovation Projects high-quality modeling and economic analysis support so communities and health systems can make better decisions about which overdose-related interventions to implement, how to implement them, and what impact and costs to expect.
Functionally, the center is meant to be a technical and analytic backbone for the Innovation Projects. A major part of the work is simulation modeling to estimate the potential public health effects of different strategies to prevent and respond to overdose. The FOA emphasizes methods such as agent-based modeling, predictive modeling, geospatial modeling, and other simulation approaches that can help translate real-world local conditions into actionable projections. In plain terms, the center should be able to help an Innovation Project compare scenarios (for example, different service configurations, targeting approaches, or implementation levels), estimate outcomes at the population level, and communicate those results in a way that supports local decision-making.
A second core function is economic analysis. The center is expected to help Innovation Projects assess costs and cost-benefit (or related economic measures) associated with proposed or ongoing service delivery changes. That includes developing practical costing tools that Innovation grantees can actually use, not just one-off analyses. These tools are intended to inform choices such as which intervention package to select, what scale is feasible, where resources are likely to have the greatest effect, and what tradeoffs might arise. Alongside this direct support role, the center is also expected to conduct original, state-of-the-art research that applies modern economic and simulation modeling techniques to deepen understanding of the overdose crisis and identify strategies that could reduce overdose morbidity and mortality.
This FOA runs in parallel with companion funding opportunities that cover other components of the HEAL D2A Program, so the Resource Center is designed to plug into a larger coordinated portfolio. Because it is a cooperative agreement, the center should be prepared for active collaboration, shared planning, and ongoing responsiveness to the needs of multiple Innovation Projects rather than serving a single site or narrow topic.
Eligibility is broad and includes many domestic organization types: state, county, and city governments; special district governments; independent school districts; public and state-controlled colleges and universities; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses); small businesses; and other entities. The FOA also explicitly highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it draws a firm boundary around foreign involvement: non-U.S. entities are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
Key administrative details from the notice include: it is a discretionary funding opportunity using the cooperative agreement funding instrument; the activity area is listed under education and health; and the CFDA numbers are 93.213, 93.279, and 93.846. The opportunity was created on January 3, 2022, with an original closing date of March 10, 2022. The listed award ceiling is $1,000,000. The FOA indicates an expectation of one award, consistent with the goal of funding a single Resource Center to support the larger set of Innovation Projects.Apply for RFA DA 22 049
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.279, 93.846.
- This funding opportunity was created on 2022-01-03.
- Applicants must submit their applications by 2022-03-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Previous opportunity: SciDAC: Partnerships in Earth System Model Development
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 22 049
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 22 049) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) Apply for RFA MH 22 170 Funding Number: RFA MH 22 170 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 22 008 Funding Number: RFA CA 22 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Apply for RFA CA 22 007 Funding Number: RFA CA 22 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 22 010 Funding Number: RFA CA 22 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 22 006 Funding Number: RFA CA 22 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 22 005 Funding Number: RFA CA 22 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| HEAL Initiative: HEAL Data2Action (HD2A) Data Infrastructure Support Center (U24 Clinical Trial Optional) Apply for RFA DA 22 052 Funding Number: RFA DA 22 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| HEAL Initiative: HEAL Data2Action Research Adoption Support Center (U2C Clinical Trial Optional) Apply for RFA DA 22 050 Funding Number: RFA DA 22 050 Agency: National Institutes of Health Category: Education, Health Funding Amount: $2,000,000 |
| Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) Apply for RFA MH 22 171 Funding Number: RFA MH 22 171 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 22 009 Funding Number: RFA CA 22 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) Apply for RFA CA 22 011 Funding Number: RFA CA 22 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) Apply for PAR 22 057 Funding Number: PAR 22 057 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Apply for RFA DA 22 037 Funding Number: RFA DA 22 037 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional) Apply for PAR 22 092 Funding Number: PAR 22 092 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) Apply for RFA DA 22 038 Funding Number: RFA DA 22 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Apply for PAR 22 091 Funding Number: PAR 22 091 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Apply for PAR 22 090 Funding Number: PAR 22 090 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) Apply for PAR 22 084 Funding Number: PAR 22 084 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed) Apply for RFA TR 22 011 Funding Number: RFA TR 22 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Stimulating Access to Research in Residency (StARR) (R38) Apply for RFA HL 23 006 Funding Number: RFA HL 23 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 22 049", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
